{"answer":{"query":"Mekinist","resolved_as":"applications","packages":4,"applications":["NDA204114","NDA217513"],"identity":{"application_numbers":["NDA204114","NDA217513"],"marketing_categories":["NDA"],"labelers":[],"dosage_forms":[{"text":"TABLET, FILM COATED","untrusted":true},{"text":"POWDER, FOR SOLUTION","untrusted":true}],"marketing_start":{"earliest":"2021-12-22","latest":"2023-03-16","packages_with_a_start_date":4}},"generic_entry":[{"application":"NDA204114","date":"2034-02-28","reading":"upper bound from listed dates, not a forecast","basis":"latest of all listed patent and exclusivity expiries in this Orange Book edition; an upper bound from listed dates only, not a forecast of launch (litigation, settlements, delisting, tentative approvals and 180-day status are not modelled)","driver":{"kind":"patent","ref":"10869869*PED","productNo":"002"},"latest_patent_expiry":"2034-02-28","latest_exclusivity_expiry":"2030-09-16","dated_barriers":60,"undated_barriers":0,"orange_book_edition":"2026-09","patents_listed":8,"exclusivities_listed":4,"fact_id":"a680ea3c9a04535e766537d0"},{"application":"NDA217513","date":"2031-04-15","reading":"upper bound from listed dates, not a forecast","basis":"latest of all listed patent and exclusivity expiries in this Orange Book edition; an upper bound from listed dates only, not a forecast of launch (litigation, settlements, delisting, tentative approvals and 180-day status are not modelled)","driver":{"kind":"patent","ref":"8703781*PED","productNo":"001"},"latest_patent_expiry":"2031-04-15","latest_exclusivity_expiry":"2030-09-16","dated_barriers":8,"undated_barriers":0,"orange_book_edition":"2026-09","patents_listed":2,"exclusivities_listed":4,"fact_id":"1a8dea9bc986560e856a26b9"}],"label_history":{"events_total":42,"non_cmc_events":40,"counts_by_class":{"LABELING":27,"EFFICACY":13},"cmc_events":2,"recent_non_cmc_events":[{"application":"NDA204114","submission_no":42,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2026-05-07","documents":[{"type":"Letter","date":"2026-05-11","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/204114Orig1s042ltr.pdf","untrusted":true}},{"type":"Label","date":"2026-05-18","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/204114s042lbl.pdf","untrusted":true}}],"fact_id":"894fbfe10e7fd6edc4cbb23e"},{"application":"NDA204114","submission_no":40,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2026-03-26","documents":[{"type":"Label","date":"2026-03-30","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/204114s040lbl.pdf","untrusted":true}},{"type":"Letter","date":"2026-03-30","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/204114Orig1s040,217513Orig1s011ltr.pdf","untrusted":true}}],"fact_id":"a21fef0920bc1f6000ab04f6"},{"application":"NDA217513","submission_no":11,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2026-03-26","documents":[{"type":"Letter","date":"2026-03-30","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/204114Orig1s040,217513Orig1s011ltr.pdf","untrusted":true}},{"type":"Label","date":"2026-04-02","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217513s011lbl.pdf","untrusted":true}}],"fact_id":"324afab4c074f2b7883196fb"},{"application":"NDA204114","submission_no":39,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2025-04-21","documents":[{"type":"Letter","date":"2025-04-25","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/204114Orig1s039ltr.pdf","untrusted":true}},{"type":"Label","date":"2025-04-25","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204114Orig1s039lbl.pdf","untrusted":true}}],"fact_id":"19bf58688846ab1af88579aa"},{"application":"NDA204114","submission_no":38,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2025-04-07","documents":[{"type":"Label","date":"2025-04-08","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204114s038,217513s009lbl.pdf","untrusted":true}},{"type":"Letter","date":"2025-04-09","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/204114Orig1s038_217513Orig1s009ltr.pdf","untrusted":true}}],"fact_id":"0bc79bf103f5b2535ccfdfc5"}],"note":"a dated list of FDA supplements and their classes, not a reading of what changed in the label"},"substitution":{"products_total":6,"te_code_counts":{"AB":2,"NOT_PROVIDED":4},"marketing_status_counts":{"Prescription":5,"Discontinued":1},"meaning":"raw FDA codes; the therapeutic equivalence code says whether FDA rates a generic as substitutable, and what that means for a given prescription is for a pharmacist or prescriber","products":[{"application":"NDA204114","product_no":"003","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"MEKINIST","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"EQ 2MG","untrusted":true}},{"application":"NDA204114","product_no":"001","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"MEKINIST","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"EQ 0.5MG","untrusted":true}},{"application":"NDA204114","product_no":"002","te_code":null,"marketing_status":"Discontinued","drug_name":{"text":"MEKINIST","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"EQ 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","untrusted":true}},{"application":"NDA217513","product_no":"003","te_code":null,"marketing_status":"Prescription","drug_name":{"text":"MEKINIST","untrusted":true},"form":{"text":"SOLUTION;ORAL","untrusted":true},"strength":{"text":"4.7MG","untrusted":true}},{"application":"NDA217513","product_no":"001","te_code":null,"marketing_status":"Prescription","drug_name":{"text":"MEKINIST","untrusted":true},"form":{"text":"SOLUTION;ORAL","untrusted":true},"strength":{"text":"EQ 0.05MG BASE/ML","untrusted":true}},{"application":"NDA217513","product_no":"002","te_code":null,"marketing_status":"Prescription","drug_name":{"text":"MEKINIST","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"2MG","untrusted":true}}]},"spending":{"reported_under":{"generic":{"text":"Trametinib Dimethyl Sulfoxide","untrusted":true},"brand":{"text":"Mekinist","untrusted":true}},"latest_year":2024,"series":[{"year":2020,"gross_spending_usd":113841285.61,"claims":10006,"beneficiaries":2044,"average_spending_per_claim_usd":11377.30218,"fact_id":"c3c364c5779fbc60944d730b"},{"year":2021,"gross_spending_usd":136778621.81,"claims":11338,"beneficiaries":2185,"average_spending_per_claim_usd":12063.734504,"fact_id":"b9d35f9d5c5e519cbb96b2bd"},{"year":2022,"gross_spending_usd":159068731.16,"claims":12245,"beneficiaries":2281,"average_spending_per_claim_usd":12990.504791,"fact_id":"c3152659ea14044cfd9ada85"},{"year":2023,"gross_spending_usd":173398802.16,"claims":12301,"beneficiaries":2289,"average_spending_per_claim_usd":14096.317548,"fact_id":"6eea51822c8163911515bc4c"},{"year":2024,"gross_spending_usd":207005040.79,"claims":14526,"beneficiaries":2654,"average_spending_per_claim_usd":14250.656808,"fact_id":"9c0eb2648d2c4c08bac0bd1f"}],"rebate_caveat":"CMS's dataset states spending is gross drug cost and does not reflect manufacturers' rebates or other price concessions.","not_a_patient_price":"Spending is the total paid by Medicare, plans and beneficiaries for the drug's claims, not what a patient pays.","meaning":"a drug-level aggregate of Medicare Part D claims for all manufacturers combined; not a formulary, not coverage","source":{"dataset":{"text":"data-year-2024, modified 2026-06-25","untrusted":true},"link":{"text":"https://data.cms.gov/summary-statistics-on-use-and-payments/medicare-medicaid-spending-by-drug/medicare-part-d-spending-by-drug","untrusted":true}}},"orphan_designation":{"ingredients":[{"ingredient":{"text":"trametinib","untrusted":true},"designation_count":2,"approved_count":2,"recent":[{"designated":"2022-06-24","use":{"text":"Treatment of malignant glioma with BRAF V600 mutation","untrusted":true},"status":"Designated/Approved","sponsor":{"text":"Novartis Pharmaceuticals Corporation","untrusted":true},"approved":true},{"designated":"2010-12-20","use":{"text":"Treatment of Stage IIb through Stage IV melanoma","untrusted":true},"status":"Designated/Approved","sponsor":{"text":"Novartis Pharmaceuticals Corp.","untrusted":true},"approved":true}],"read_on":"2026-11-07T12:00:00.000Z","fact_id":"2f46d0a1a11026dc17636cde"}],"reading":"a designation is not an approval and not a statement that the drug treats the condition; status is the FDA database's own"},"medicaid_state_utilization":{"year":2025,"states_with_data":10,"all_states_medicaid_reimbursed_usd":6417116.98,"all_states_medicaid_paid_prescriptions":712,"top_states":[{"state":"CT","medicaid_paid_prescriptions":66,"medicaid_reimbursed_usd":1120453.38,"total_reimbursed_usd":1120453.38,"packages":1,"covers":"all_record_types","fact_id":"4061087e1ef28ff2c8017945"},{"state":"PR","medicaid_paid_prescriptions":68,"medicaid_reimbursed_usd":1101436.11,"total_reimbursed_usd":1146037.33,"packages":1,"covers":"all_record_types","fact_id":"de3f4f3774f496c123d7a10d"},{"state":"TX","medicaid_paid_prescriptions":56,"medicaid_reimbursed_usd":847271.57,"total_reimbursed_usd":916380.06,"packages":1,"covers":"fee_for_service_only","fact_id":"64c215996ac41c02d8078b10"},{"state":"CO","medicaid_paid_prescriptions":103,"medicaid_reimbursed_usd":730789.12,"total_reimbursed_usd":733065.19,"packages":1,"covers":"all_record_types","fact_id":"57462f40adb593f3e8d35cf7"},{"state":"NM","medicaid_paid_prescriptions":63,"medicaid_reimbursed_usd":598314.39,"total_reimbursed_usd":603203.81,"packages":1,"covers":"all_record_types","fact_id":"e36aa6a75b337101b1d80f78"},{"state":"IL","medicaid_paid_prescriptions":79,"medicaid_reimbursed_usd":573454.76,"total_reimbursed_usd":573454.76,"packages":1,"covers":"fee_for_service_only","fact_id":"880f022f317c2949e7f194a4"},{"state":"AZ","medicaid_paid_prescriptions":76,"medicaid_reimbursed_usd":505775.95,"total_reimbursed_usd":512956.13,"packages":1,"covers":"all_record_types","fact_id":"b7fbc5333c18a25200be365d"},{"state":"NC","medicaid_paid_prescriptions":74,"medicaid_reimbursed_usd":472859.16,"total_reimbursed_usd":472859.16,"packages":1,"covers":"fee_for_service_only","fact_id":"56dbc5944dd93141ed8ebf15"},{"state":"MI","medicaid_paid_prescriptions":65,"medicaid_reimbursed_usd":245434.74,"total_reimbursed_usd":324767.83,"packages":1,"covers":"all_record_types","fact_id":"509725d4a3520d7dfd721d4a"},{"state":"MO","medicaid_paid_prescriptions":62,"medicaid_reimbursed_usd":221327.8,"total_reimbursed_usd":221327.8,"packages":1,"covers":"all_record_types","fact_id":"79b0a9d43d4eab804a231539"}],"unlabelled_state_code_xx":null,"built_from_facts":10,"facts_fee_for_service_only":3,"older_year_facts_not_used":39,"dataset":"State Drug Utilization Data 2025","read_on":"2026-11-07T22:41:44.201Z","reading":"Medicaid prescriptions and reimbursement by state (CMS State Drug Utilization Data). Reimbursement is before manufacturer rebates: not a net cost, not a patient price. Suppressed managed-care cells make a state figure fee-for-service only. An absent state was suppressed or unreported, not zero.","receipts_note":"a receipt is held for the largest fact behind each state shown; every figure is a sum of the built_from_facts facts, each recomputable from its recorded input hash"}},"receipts":[{"fact_id":"8b3cbd6a14df89f538d4d86a","field":"ndc.listing","entity":"ndc:00078110515"},{"fact_id":"5d7a17bba633afc77560a625","field":"ndc.listing","entity":"ndc:00078111215"},{"fact_id":"0c4160488fc80aa9f0c7d267","field":"ndc.listing","entity":"ndc:00078111294"},{"fact_id":"a680ea3c9a04535e766537d0","field":"drug.generic_entry_earliest","entity":"application:NDA204114"},{"fact_id":"1d3df30af6a25d03031ef2bb","field":"drug.patent","entity":"application:NDA204114"},{"fact_id":"9c530c398cf3ffe22f3a91cf","field":"drug.exclusivity","entity":"application:NDA204114"},{"fact_id":"1a8dea9bc986560e856a26b9","field":"drug.generic_entry_earliest","entity":"application:NDA217513"},{"fact_id":"743dffd5c291e5c32a7d9d0c","field":"drug.patent","entity":"application:NDA217513"},{"fact_id":"4d0d0436738e8cbb028861a0","field":"drug.exclusivity","entity":"application:NDA217513"},{"fact_id":"894fbfe10e7fd6edc4cbb23e","field":"drug.label_event","entity":"application:NDA204114"},{"fact_id":"a21fef0920bc1f6000ab04f6","field":"drug.label_event","entity":"application:NDA204114"},{"fact_id":"324afab4c074f2b7883196fb","field":"drug.label_event","entity":"application:NDA217513"},{"fact_id":"19bf58688846ab1af88579aa","field":"drug.label_event","entity":"application:NDA204114"},{"fact_id":"0bc79bf103f5b2535ccfdfc5","field":"drug.label_event","entity":"application:NDA204114"},{"fact_id":"a98aa9b831e04dcf1ac65373","field":"drug.te_code","entity":"application:NDA204114"},{"fact_id":"ea1421171b44ba592690541d","field":"drug.marketing_status","entity":"application:NDA204114"},{"fact_id":"391fa0c19c75846024688cd2","field":"drug.te_code","entity":"application:NDA204114"},{"fact_id":"89ac7517e9e5658a8188c64a","field":"drug.marketing_status","entity":"application:NDA204114"},{"fact_id":"7b210fe9a85ad566d1a586e8","field":"drug.marketing_status","entity":"application:NDA204114"},{"fact_id":"d3633846101ae87e572d2302","field":"drug.marketing_status","entity":"application:NDA217513"},{"fact_id":"6770636674d61837c96c7670","field":"drug.marketing_status","entity":"application:NDA217513"},{"fact_id":"5bd26c01eb44353f17ad87c4","field":"drug.marketing_status","entity":"application:NDA217513"},{"fact_id":"c3c364c5779fbc60944d730b","field":"drug.partd_spending","entity":"drug:trametinib-dimethyl-sulfoxide|mekinist"},{"fact_id":"b9d35f9d5c5e519cbb96b2bd","field":"drug.partd_spending","entity":"drug:trametinib-dimethyl-sulfoxide|mekinist"},{"fact_id":"c3152659ea14044cfd9ada85","field":"drug.partd_spending","entity":"drug:trametinib-dimethyl-sulfoxide|mekinist"},{"fact_id":"6eea51822c8163911515bc4c","field":"drug.partd_spending","entity":"drug:trametinib-dimethyl-sulfoxide|mekinist"},{"fact_id":"9c0eb2648d2c4c08bac0bd1f","field":"drug.partd_spending","entity":"drug:trametinib-dimethyl-sulfoxide|mekinist"},{"fact_id":"2f46d0a1a11026dc17636cde","field":"drug.orphan_designation","entity":"drug:trametinib"},{"fact_id":"4061087e1ef28ff2c8017945","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00078111215:CT"},{"fact_id":"de3f4f3774f496c123d7a10d","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00078111215:PR"},{"fact_id":"64c215996ac41c02d8078b10","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00078111215:TX"},{"fact_id":"57462f40adb593f3e8d35cf7","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00078110515:CO"},{"fact_id":"e36aa6a75b337101b1d80f78","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00078110515:NM"},{"fact_id":"880f022f317c2949e7f194a4","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00078110515:IL"},{"fact_id":"b7fbc5333c18a25200be365d","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00078116147:AZ"},{"fact_id":"56dbc5944dd93141ed8ebf15","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00078116147:NC"},{"fact_id":"509725d4a3520d7dfd721d4a","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00078116147:MI"},{"fact_id":"79b0a9d43d4eab804a231539","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00078116147:MO"}],"as_of":{"newest_fact_retrieved_at":"2026-11-10T20:02:39.475Z"},"edition":{"id":"2026-11","merkleRoot":"006ab9a329709cbe7f56a0e1a7c4a02f897655cdfecf9ca34d199690095adcb6","factCount":212100,"manifestPresent":true},"licence":{"classes":["GREEN"],"note":"Source records are public; this compilation is cited with attribution. See the provenance tool for each fact's licence label."},"unknown":[{"code":"NO_DATA","field":"price","reason":"no NADAC price, negotiated price or federal upper limit for these packages"},{"code":"NO_DATA","field":"recalls","reason":"no FDA enforcement report naming a package of these applications is recorded"},{"code":"NO_DATA","field":"supply","reason":"no FDA shortage row and no termination date for these packages"},{"code":"NO_DATA","field":"trials","reason":"no ClinicalTrials.gov record set for this drug's ingredient is in the edition"},{"code":"NO_DATA","field":"assistance_and_offers","reason":"no assistance program lists this drug and no manufacturer offer naming it is recorded; that does not mean none exists"},{"code":"NO_DATA","field":"policy","reason":"no Federal Register event in the edition names this drug or its programs"},{"code":"NO_DATA","field":"biologic_status","reason":"no biologic application of this drug has a Purple Book status in the edition (a drug that is not a biologic has none)"},{"code":"NO_DATA","field":"payment_limit","reason":"no HCPCS code whose NDC crosswalk names a package of these applications has a Part B payment limit in the edition"},{"code":"NO_DATA","field":"rems","reason":"no REMS@FDA program is tied to these applications in the edition (most drugs have none)"},{"code":"NO_DATA","field":"controlled_schedule","reason":"no DEA schedule entry matched this drug's ingredient in the edition"},{"code":"NO_DATA","field":"safety_communication","reason":"no FDA Drug Safety Communication names this drug's ingredient in the edition"}],"disclaimer":"OmniRx is a reference layer of dated public facts, not clinical advice and not a guarantee of price, coverage or eligibility. Each answer lists the facts it rests on."}